Comerica Bank
NAUT icon

Comerica Bank’s Nautilus Biotechnolgy NAUT Stock Holding History

Comerica Bank’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,209
Closed -$2.03K – 3740
2024
Q4 		$2.03K Hold
1,209
– – ﹤0.01% 3484
2024
Q3 		$3.45K Hold
1,209
– – ﹤0.01% 3403
2024
Q2 		$2.83K Hold
1,209
– – ﹤0.01% 3415
2024
Q1 		$3.55K Hold
1,209
– – ﹤0.01% 3408
2023
Q4 		$3.62K Sell
1,209
-555
-31% -$1.59K ﹤0.01% 3393
2023
Q3 		$5.57K Buy
+1,764
New +$5.74K ﹤0.01% 3337

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

Comerica Bank's NAUT Position: Q1 2025 in Review

Comerica Bank sold out of Nautilus Biotechnolgy (NAUT) in Q1 2025, closing a stake of 1,209 shares — an estimated $2.03K sold.

Comerica Bank first reported a position in NAUT in Q3 2023 and held it in 6 quarters. The position peaked at $5.57K in Q3 2023. 88 funds tracked by Wall St. Rank hold NAUT as of Q1 2025.

  • Comerica Bank reported no remaining Nautilus Biotechnolgy position as of Q1 2025 after selling out during the quarter.
  • Comerica Bank sold 1,209 Nautilus Biotechnolgy shares in Q1 2025, an estimated $2.03K.
  • Comerica Bank first reported a position in Nautilus Biotechnolgy in Q3 2023 and held it in 6 quarters.
  • Comerica Bank's Nautilus Biotechnolgy position peaked at $5.57K in Q3 2023.
  • 88 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2025.

Based on Comerica Bank's 13F filing for Q1 2025, filed 14 May 2025.